Response Genetics, Inc
RGDXQ
$0.00
$0.000.00%
OTC PK
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Revenue | -8.06% | -15.56% | -15.26% | -22.05% | -11.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.06% | -15.56% | -15.26% | -22.05% | -11.32% |
| Cost of Revenue | 0.07% | 0.34% | -4.39% | -2.77% | 1.09% |
| Gross Profit | -18.97% | -33.35% | -26.62% | -39.96% | -23.88% |
| SG&A Expenses | 10.83% | 14.68% | 35.20% | 27.61% | 21.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.42% | 8.87% | 18.19% | 14.28% | 11.61% |
| Operating Income | -28.30% | -69.74% | -148.74% | -214.32% | -99.04% |
| Income Before Tax | -32.83% | -70.80% | -152.83% | -211.66% | -96.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -32.83% | -70.80% | -152.83% | -211.66% | -96.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.83% | -70.80% | -152.83% | -211.66% | -96.10% |
| EBIT | -28.30% | -69.74% | -148.74% | -214.32% | -99.04% |
| EBITDA | -29.19% | -73.12% | -161.62% | -239.96% | -105.01% |
| EPS Basic | -22.11% | -50.53% | -119.13% | -156.61% | -44.38% |
| Normalized Basic EPS | -26.14% | -55.75% | -119.11% | -156.66% | -44.35% |
| EPS Diluted | -22.11% | -50.53% | -119.13% | -156.61% | -44.38% |
| Normalized Diluted EPS | -26.14% | -55.75% | -119.11% | -156.66% | -44.35% |
| Average Basic Shares Outstanding | 10.21% | 14.99% | 15.73% | 17.53% | 21.46% |
| Average Diluted Shares Outstanding | 10.21% | 14.99% | 15.73% | 17.53% | 21.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |